You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 26, 2024

Litigation Details for Novo Nordisk Inc. v. Teva Pharmaceuticals, Inc. (D. Del. 2021)

✉ Email this page to a colleague

« Back to Dashboard

Novo Nordisk Inc. v. Teva Pharmaceuticals, Inc. (D. Del. 2021)

Docket	⤷ Sign Up	Date Filed	2021-12-21
Court	District Court, D. Delaware	Date Terminated	2023-09-25
Cause	35:271 Patent Infringement	Assigned To	Colm Felix Connolly
Jury Demand	None	Referred To
Parties	TEVA PHARMACEUTICALS USA, INC.
Patents	10,220,155; 10,357,616; 10,376,652; 7,762,994; 8,114,833; 8,684,969; 8,920,383; 9,108,002; 9,132,239; 9,265,893; 9,457,154; 9,616,180; 9,687,611; 9,775,953; 9,861,757; 9,968,659; RE46,363
Attorneys	Nathan Roger Hoeschen
Firms	Shaw Keller LLP, DE
Link to Docket	External link to docket

Small Molecule Drugs cited in Novo Nordisk Inc. v. Teva Pharmaceuticals, Inc.

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Biologic Drugs cited in Novo Nordisk Inc. v. Teva Pharmaceuticals, Inc.

The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Details for Novo Nordisk Inc. v. Teva Pharmaceuticals, Inc. (D. Del. 2021)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2021-12-21	1	Complaint	the “’953 patent”), 9,861,757 (the “’757 patent”), 9,968,659 (the “’659 patent”), 10,220,155 (the “’155… COUNT FOR INFRINGEMENT OF U.S. PATENT NO. 10,220,155 107. Novo Nordisk re-alleges… United States Patent Nos. 7,762,994 (the “’994 patent”), 8,114,833 (the “’833 patent”), 8,684,969 (the…(the “’969 patent”), 8,920,383 (the “’383 patent”), 9,108,002 (the “’002 patent”), 9,132,239 (the “’239…’239 patent”), 9,457,154 (the “’154 patent”), 9,616,180 (the “’180 patent”), 9,687,611 (the “’611 patent	External link to document
2023-04-14	104	Notice of Service	Preliminary Invalidity Contentions Regarding U.S. Patent Nos. 8,114,833; 9,101,718; and 9,265,893 - filed by Novo… 25 September 2023 1:21-cv-01782 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2023-04-28	106	Notice of Service	. Tessier, Ph.D. Regarding Patent Infringement of U.S. Patent No. 8,114,833 and Exhibits A-B; (4) Opening… 25 September 2023 1:21-cv-01782 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2023-05-01	107	Notice of Service	Robert J. Orr on the Invalidity of U.S. Patent No. 8,114,833 filed by Teva Pharmaceuticals USA, Inc.,…Karl R. Leinsing M.S.M.E., P.E. Invalidity of U.S. Patent Nos. 9,265,893 and 9,101,718 2) Opening Expert … 25 September 2023 1:21-cv-01782 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2023-05-26	108	Notice of Service	Tessier, Ph.D. Regarding Validity of U.S. Patent No. 8,114,833; (2) Rebuttal Expert Report of Kimberly …Virender Kumar Sarin Regarding Validity of U.S. Patent No. 8,114,833 filed by Novo Nordisk A/S, Novo Nordisk …Ph.D. Regarding Validity of U.S. Patent No. 9,265,893 and U.S. Patent No. 9,101,718; and (3) Rebuttal … 25 September 2023 1:21-cv-01782 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.